Jan Cato Holter

ORCID: 0000-0003-1618-5022
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 detection and testing
  • Respiratory viral infections research
  • COVID-19 and healthcare impacts
  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Intensive Care Unit Cognitive Disorders
  • Immune responses and vaccinations
  • COVID-19 and Mental Health
  • Respiratory Support and Mechanisms
  • COVID-19 Impact on Reproduction
  • Nosocomial Infections in ICU
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Liver Disease Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Inflammasome and immune disorders
  • Sepsis Diagnosis and Treatment
  • Antibiotic Resistance in Bacteria
  • Pancreatitis Pathology and Treatment
  • Colorectal Cancer Treatments and Studies
  • Emergency and Acute Care Studies
  • Complement system in diseases

UnityPoint Health
2025

University of Oslo
2014-2024

Oslo University Hospital
1984-2024

Johns Hopkins Hospital
2024

University of Oxford
2021

Drammen Hospital
2016-2019

Vestre Viken Hospital Trust
2015-2019

Akershus University Hospital
2014

Institutt for Eksperimentell Medisinsk Forskning
1981-1982

Significance The new SARS-CoV-2 pandemic leads to COVID-19 with respiratory failure, substantial morbidity, and significant mortality. Overactivation of the innate immune response is postulated trigger this detrimental process. complement system a key player in immunity. Despite few reports local activation, there lack evidence that degree systemic activation occurs early patients, whether associated failure. This study shows number products are systemically, consistently, long-lastingly...

10.1073/pnas.2010540117 article EN cc-by Proceedings of the National Academy of Sciences 2020-09-17

Despite recent advances in microbiological techniques, the etiology of community-acquired pneumonia (CAP) is still not well described. We applied polymerase chain reaction (PCR) and conventional methods to describe CAP hospitalized adults evaluated their respective diagnostic yields. 267 patients were enrolled consecutively over our 3-year prospective study. Conventional (i.e., bacterial cultures, urinary antigen assays, serology) combined with nasopharyngeal (NP) oropharyngeal (OP) swab...

10.1186/s12879-015-0803-5 article EN cc-by BMC Infectious Diseases 2015-02-15

A high proportion of COVID-19 patients have cardiac involvement, even those without known disease. Downregulation angiotensin converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 and the renin-angiotensin system, as well inflammatory mechanisms been suggested to play role. ACE2 is abundant in gut associated with microbiota composition. We hypothesized that leakage microbial products, subsequent inflammasome activation could contribute involvement patients.Plasma levels marker (LPS-binding...

10.1111/joim.13178 article EN cc-by Journal of Internal Medicine 2020-09-25

Abstract In SARS-CoV-2 infection there is an urgent need to identify patients that will progress severe COVID-19 and may benefit from targeted treatment. this study we analyzed plasma cytokines in investigated their association with respiratory failure (RF) treatment Intensive Care Unit (ICU). Hospitalized (n = 34) confirmed were recruited into a prospective cohort study. Clinical data blood samples collected at inclusion after 2–5 7–10 days. RF was defined as PaO2/FiO2 ratio (P/F) < 40...

10.1038/s41598-020-78710-7 article EN cc-by Scientific Reports 2020-12-10

Introduction Very little is known about possible clinical sequelae that may persist after resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients followed up hospitalisation with COVID-19 reported 87% had at least one ongoing symptom 60-day follow-up. Early indications suggest need even more psychological support than typical intensive care unit patients. The assessment risk factors for longer term consequences requires a study linked to data on...

10.1136/bmjopen-2020-043887 article EN cc-by-nc-nd BMJ Open 2021-03-01

To test the hypotheses that blood biomarkers for nervous system injury, serum concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic (GFAp) can serve as disease severity in COVID-19 patients.Forty-seven inpatients with confirmed had samples drawn on admission assessing CNS injury by Single molecule array (Simoa), NfL GFAp. Concentrations GFAp were analyzed relation to symptoms, clinical signs, inflammatory outcomes. We used multivariate linear models...

10.1007/s00415-021-10517-6 article EN cc-by Journal of Neurology 2021-03-20

To determine the incidence and characteristics of superinfections in mechanically ventilated COVID-19 patients, impact dexamethasone as standard therapy.This multicentre, observational, retrospective study included patients ≥ 18 years admitted from March 1st 2020 to January 31st 2021 with infection who received mechanical ventilation. Patient characteristics, clinical therapy survival were examined.155/156 (115 men, mean age 62 years, range 26-84 years) included. 67 (43%) had 90...

10.1016/j.jinf.2022.05.015 article EN cc-by Journal of Infection 2022-05-21

Gut microbiota alterations have been reported in hospitalized COVID-19 patients, with reduced alpha diversity and altered composition related to respiratory failure. However, data regarding gut mortality are scarce.Rectal swabs for analyses were collected within 48 h after hospital admission (baseline; n = 123) three-month post-admission (n 50) a subset of patients included the Norwegian SARS-CoV2 cohort study. Samples analysed by sequencing 16S rRNA gene. at baseline assessed relation need...

10.1186/s13054-023-04356-2 article EN cc-by Critical Care 2023-02-23

Background Contributors to long-term mortality in patients with community-acquired pneumonia (CAP) remain unclear, little attention paid etiology. We examined survival, causes of death, and risk factors for adult who had been hospitalized CAP, emphasis on demographic, clinical, laboratory, microbiological characteristics. Methods Two hundred sixty-seven consecutive admitted 2008–2011 a general hospital CAP were prospectively recruited followed up. Patients died during stay excluded....

10.1371/journal.pone.0148741 article EN cc-by PLoS ONE 2016-02-05

Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure levels antibodies receptor-binding domain ancestral SARS-CoV-2 (RBDwt). However, predictive value for protection against new variants concern (VOCs) has not been firmly established. Here, we bead-based arrays and flow cytometry binding spike proteins domains (RBDs) from VOCs in 12,000 serum samples. Effects sera on RBD-ACE2 interactions were measured as a proxy neutralizing antibodies. The samples obtained...

10.1038/s41541-022-00586-7 article EN cc-by npj Vaccines 2022-12-30

Abnormal remodelling of the extracellular matrix (ECM) has generally been linked to pulmonary inflammation and fibrosis may also play a role in pathogenesis severe COVID-19. To further elucidate ECM excessive fibrogenesis COVID-19, we examined circulating levels mediators involved various aspects these processes COVID-19 patients.

10.1111/joim.13725 article EN cc-by Journal of Internal Medicine 2023-09-18

Abstract Background The complement system, an upstream recognition system of innate immunity, is activated upon SARS‐CoV‐2 infection. To gain a deeper understanding the extent and duration this activation, we investigated activation profiles during acute phase COVID‐19, its persistence post‐recovery dynamic changes in relation to disease severity. Methods Serial blood samples were obtained from two cohorts hospitalized COVID‐19 patients ( n = 457). Systemic products reflecting...

10.1111/joim.13783 article EN cc-by-nc-nd Journal of Internal Medicine 2024-03-27

A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae populations globally and compare prevalence reported symptoms HICs low-income middle-income (LMICs).

10.1136/bmjgh-2024-015245 article EN cc-by-nc-nd BMJ Global Health 2024-10-01
Anders Tveita Sarah Louise Murphy Jan Cato Holter Anders Benjamin Kildal Annika E. Michelsen and 95 more Tøri Vigeland Lerum Mari Kaarbø Lars Heggelund Aleksander Rygh Holten Ane-Kristine Finbråten Karl Erik Müller Alexander Mathiessen Simen Bøe Børre Fevang Beathe Kiland Granerud Kristian Tonby Andreas Lind Susanne Dudman Kateřina Nezvalová‐Henriksen Fredrik Müller Ole Henning Skjønsberg Marius Trøseid Andreas Barratt‐Due Anne Ma Dyrhol‐Riise Pål Aukrust Bente Halvorsen Tuva B. Dahl Thor Ueland Cathrine Austad Mette Bogen Anne Pernille Hermann Hanne Opsand Trude Steinsvik Bjørn Martin Woll Erik Egeland Christensen Kristin Eftestøl Liv Hesstvedt Synne Jenum Marthe Jøntvedt Jørgensen Elisabeth Toverud Landaas Sarah Nur Vidar Ormaasen Frank Olav Pettersen Else Quist‐Paulsen Dag Henrik Reikvam Kjerstin Røstad Linda Gail Skeie Anne Katrine Steffensen Birgitte Stiksrud Berit Gravrok Vegard Skogen Garth D. Tylden Jan Terje Andersen Anette Kolderup Trine Kåsine Fridtjof Lund‐Johansen Inge Christoffer Olsen Karoline H. Skåra Trung Tran Cathrine Fladeby Liv Hesstvedt Mona Holberg‐Petersen Synne Jenum Simreen Kaur Johal Dag Henrik Reikvam Kjerstin Røstad Anne Katrine Steffensen Birgitte Stiksrud Eline Brenno Vaage Erik Egeland Christensen Marthe Jøntvedt Jørgensen Sarah Nur Vidar Ormaasen Frank Olav Pettersen Saad Aballi Jorunn Brynhildsen Waleed Ghanima Anne Marie Halstensen Åse Berg Bjørn Blomberg Reidar Kvåle Nina Langeland Kristin Greve Isdahl Mohn Olav Dalgård Ragnhild Eiken Richard Alexander Molvik Carl Magnus Ystrøm Gernot Ernst Lars Thoresen Lise Tuset Gustad Lars Mølgaard Saxhaug Nina Vibeche Skei Raisa Hannula Mette Haugli Roy Bjørkholt Olsen Hedda Hoel Dag Arne Lihaug Hoff Asgeir Johannessen Bjørn Åsheim-Hansen Bård Reikvam Kittang

Abstract Background Immune dysregulation is a major factor in the development of severe coronavirus disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been implicated as mediators tissue inflammation, but data on their regulation acute respiratory syndrome 2 (SARS-CoV-2) infection limited. We thus investigated levels these COVID-19 patients. Methods Serial blood samples were obtained from patients hospitalized with (n = 414). Circulating during hospitalization 3-month...

10.1093/infdis/jiac313 article EN cc-by-nc-nd The Journal of Infectious Diseases 2022-07-25

Abstract Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon possible after acceptance. Accepted have been peer-reviewed and copyedited, but are posted before technical formatting author proofing. These not final version record will be replaced with article (formatted per style proofed by authors) at a later time. Purpose The prevalence Candida infections increases each year in US. most common species albicans, glabrata, parapsilosis,...

10.1093/ajhp/zxaf070 article EN American Journal of Health-System Pharmacy 2025-03-22

Objective. Based on the function of fractalkine (CX3CL1), unique member CX3C chemokine subfamily, in endothelial-related inflammation, we hypothesized a role for CX3CL1 and its receptor (CX3CR) Wegener's granulomatosis (WG). In present study, this hypothesis was tested by different experimental approaches. Methods. We examined plasma levels (enzyme immunoassay) CX3CR1 expression peripheral blood mononuclear cells (PBMCs) (real-time quantitative RT-PCR flow cytometry) 18 WG patients 15...

10.1093/rheumatology/kem168 article EN Lara D. Veeken 2007-06-27

Abstract Background The inflammatory response to community‐acquired pneumonia ( CAP ) is orchestrated through activation of cytokine networks and the complement system. We examined association multiple cytokines terminal complex TCC with microbial aetiology, disease severity short‐term outcome. Materials methods Plasma levels 27 were analysed in blood samples obtained at hospital admission, clinical stabilization 6‐week follow‐up from 247 hospitalized adults . Fourteen mediators included...

10.1111/eci.12865 article EN cc-by-nc European Journal of Clinical Investigation 2017-11-24

Biomarkers may facilitate clinical decisions in order to guide antimicrobial treatment and prediction of prognosis community-acquired pneumonia (CAP). We measured serum C-reactive protein, procalcitonin (PCT) calprotectin levels, plasma pentraxin 3 (PTX3) presepsin along with whole-blood white cell counts, at three time-points, examined their association microbial aetiology adverse outcomes CAP.Blood samples were obtained hospital admission, stabilisation 6-week follow-up from 267...

10.1183/23120541.00014-2019 article EN cc-by-nc ERJ Open Research 2019-02-01

Abstract Background Prognostic markers for disease severity and identification of therapeutic targets in COVID‐19 are urgently needed. We have studied innate adaptive immunity on protein transcriptomic level patients with different at admission longitudinally during hospitalization. Methods Peripheral blood mononuclear cells (PBMCs) were collected three time points from 31 included the Norwegian SARS‐CoV‐2 cohort study analysed by flow cytometry RNA sequencing. Patients grouped as either...

10.1111/joim.13310 article EN cc-by-nc-nd Journal of Internal Medicine 2021-06-03

Abstract Background There is considerable variability in COVID-19 outcomes amongst younger adults—and some of this variation may be due to genetic predisposition. We characterized the clinical implications major risk factor for severity, and its age-dependent effect, using individual-level data a large international multi-centre consortium. Method The common chromosome 3 locus, tagged by marker rs10490770. combined individual level 13,424 positive patients (N=6,689 hospitalized) from 17...

10.1101/2021.03.07.21252875 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2021-03-12

Background Results showing that sera from double vaccinated individuals have minimal neutralizing activity against Omicron been interpreted as indicating the need for a third vaccine dose protection. However, there is little information about early immune responses to infection in individuals. Methods We measured inflammatory mediators, antibodies SARS-CoV-2 spike and nucleocapsid proteins, peptide-induced release of interferon gamma whole blood 51 double-vaccinated infected with Omicron, 14...

10.3389/fimmu.2022.964525 article EN cc-by Frontiers in Immunology 2022-09-08

The Omicron variant of SARS-CoV-2 spreads more easily than earlier variants, possibly as a result higher viral load in the upper respiratory tract and oral cavity. Hence, we investigated whether generates that Delta saliva nasopharynx. Both specimens were collected from 52 17 cases at two time points one week apart analyzed by qRT-PCR. Viral was measured 10 log RNA genome copies per 1000 human cells according to WHO reference standard. We found carried had sustained shedding compared cases,...

10.3390/v14112420 article EN cc-by Viruses 2022-10-31
Coming Soon ...